Racial and ethnic disparities in genomic testing among lung cancer patients: a systematic review
View abstract on PubMed
Summary
This summary is machine-generated.Racial and ethnic disparities exist in lung cancer genomic testing, with Black patients often receiving it less frequently. These disparities may limit access to precision cancer therapies and impact survival outcomes.
Area Of Science
- Oncology
- Genomics
- Health Disparities
Background
- Genomic testing is crucial for precision cancer therapies in lung cancer.
- Existing research on racial and ethnic disparities in genomic testing shows mixed results.
- Disparities in testing could worsen inequities in cancer treatment and survival.
Conclusions
- A majority of studies indicate racial and ethnic disparities in lung cancer genomic testing.
- Black patients, in particular, may face barriers to genomic testing, contributing to health inequities.
- Despite changing guidelines, disparities persist, highlighting the need for further investigation and intervention.

